1. Home
  2. SCVL vs PRTA Comparison

SCVL vs PRTA Comparison

Compare SCVL & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shoe Carnival Inc.

SCVL

Shoe Carnival Inc.

HOLD

Current Price

$20.07

Market Cap

511.9M

ML Signal

HOLD

Logo Prothena Corporation plc

PRTA

Prothena Corporation plc

HOLD

Current Price

$9.04

Market Cap

482.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCVL
PRTA
Founded
1978
2012
Country
US
US
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
511.9M
482.3M
IPO Year
1994
2013

Fundamental Metrics

Financial Performance
Metric
SCVL
PRTA
Price
$20.07
$9.04
Analyst Decision
Hold
Buy
Analyst Count
1
9
Target Price
N/A
$18.86
AVG Volume (30 Days)
279.2K
364.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
3.01%
N/A
EPS Growth
N/A
17.75
EPS
1.57
N/A
Revenue
$1,202,885,000.00
$814,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1,183.79
P/E Ratio
$12.73
N/A
Revenue Growth
2.30
N/A
52 Week Low
$15.21
$4.32
52 Week High
$26.54
$16.67

Technical Indicators

Market Signals
Indicator
SCVL
PRTA
Relative Strength Index (RSI) 55.23 47.87
Support Level $19.44 $8.80
Resistance Level $20.72 $9.23
Average True Range (ATR) 0.73 0.45
MACD -0.04 0.04
Stochastic Oscillator 67.64 78.71

Price Performance

Historical Comparison
SCVL
PRTA

About SCVL Shoe Carnival Inc.

Shoe Carnival Inc is a family footwear retailer that offers a broad assortment of dress, casual, and athletic footwear for men, women, and children with an emphasis on national name brands such as Nike, Skechers, Adidas, Puma, HEYDUDE, Converse, Vans, and Crocs. The company operates its business as one reportable segment based on the similar nature of products sold; merchandising, distribution, and marketing processes involved; target customers; and economic characteristics of stores and e-commerce platforms. Its bricks-first, omnichannel approach provides customers easy access to a wide assortment of branded footwear for work, athletics, daily activities, and special events via a choice of delivery channels.

About PRTA Prothena Corporation plc

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.

Share on Social Networks: